NCT05983770: An ongoing trial by Eledon Pharmaceuticals
This trial is ongoing. It must report results 5 months, 1 week from now.
Full data
| Full entry on ClinicalTrials.gov | NCT05983770 |
|---|---|
| Title | AT-1501-K207: BESTOW: A Phase 2, Multicenter, Randomized, Open-Label Study to Evaluate the Safety and Efficacy of Tegoprubart in Patients Undergoing Kidney Transplantation |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Aug. 30, 2023 |
| Completion date | Sept. 11, 2025 |
| Required reporting date | Sept. 11, 2026, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | March 26, 2026 |
| Days late | None |